Navigating Medicinal Cannabis and Road Safety in Australia

In Australia, driving under the influence of substances, including THC, is a serious offence. As medicinal cannabis prescriptions become more prevalent for various health conditions, the intersection of road safety and medicinal cannabis use poses critical questions for healthcare providers. How can healthcare professionals ensure their patients are well-informed about the risks of driving when prescribed medicinal cannabis?

The Growth of Medicinal Cannabis Use

As the use of medicinal cannabis continues to expand, healthcare professionals are tasked with guiding patients in understanding the potential impacts on their driving capabilities. A notable project has been initiated to create guidance materials tailored for healthcare providers who prescribe medicinal cannabis. This comprehensive resource aims to enhance decision-making and communication regarding road safety.

Guidelines Development and Collaboration

Developed in collaboration with Road Safety Victoria, the guidelines have undergone rigorous evaluation through a sub-committee of general practitioners (GPs) specializing in medicinal cannabis. Associate Professor Vicki Kotsirilos, a pioneering prescriber with nearly 40 years of experience in clinical practice, plays a pivotal role on the expert committee responsible for these guidelines.

These guidelines serve as a valuable tool for GPs across Australia, enabling them to have essential discussions with patients about driving considerations throughout the treatment process. “The information and resources are an excellent guide for conversations with our patients about driving,” said Associate Professor Kotsirilos, emphasizing that these principles can apply throughout the country.

Key Resources for Healthcare Professionals

The newly developed resources include:

• Decision Support Tool: A practical tool that aids GPs in making informed decisions regarding medicinal cannabis prescriptions.
• Driving Needs Checklist: A checklist designed to help healthcare professionals assess a patient’s driving-related factors.
• Patient Factsheet: A resource that provides patients with critical information about cannabis use and driving safety.

Understanding the Legal Implications

Under Australia’s Presence Law, any detectable THC level in a driver’s system constitutes an offence, regardless of medicinal cannabis prescriptions. This legal framework underscores the necessity for prescribers to proactively engage patients in discussions about driving risks. “Impairment generally increases as THC levels increase in the blood and saliva,” states Kotsirilos, highlighting the complexity of determining impairment.

Educating Patients on THC and Driving Implications

It is essential for healthcare providers to educate patients on how THC influences their driving abilities. “Some patients may be sensitive to even very low levels of THC,” Kotsirilos warns, emphasizing that blood and saliva THC levels do not always correlate with impairment levels. Additionally, factors such as fatigue, alcohol consumption, and the use of other sedative medications need to be considered when discussing medicinal cannabis prescriptions.

Contraindications for Specific Roles

Kotsirilos also points out that THC-containing products are strictly contraindicated for individuals in specific driving roles, including:

• Commercial vehicle drivers
• Heavy vehicle operators
• Public passenger vehicle drivers
• Dangerous goods drivers
• Emergency vehicle operators

If a patient cannot adhere to the recommendations for safe driving, prescribing THC-containing products may not be appropriate.

Alternative Options: CBD-Only Medicines

For patients who need to drive, Associate Professor Kotsirilos advises considering CBD-only products. “Patients taking CBD-only products can drive unless they feel impaired,” she explains, pointing out the importance of distinguishing between THC and CBD in terms of driving safety.

Implementing Informed Consent

Healthcare professionals are encouraged to implement informed consent practices. Kotsirilos believes that providing patients with clear guidance and obtaining their acknowledgment of understanding regarding the risks of THC can lead to safer decision-making. The RACGP’s declaration form includes critical information about risks, side effects, and the necessity to avoid driving while using THC products.

The Role of Trust in Healthcare

As GPs are often viewed as trusted healthcare advisors, establishing early conversations about driving is essential. Kotsirilos notes that ongoing dialogue not only assists patients in making informed decisions regarding medicinal cannabis treatment but also helps determine when they should report their medical conditions to the Department of Transport Medical Review.

Healthcare professionals should encourage patients to disclose any medications or medical conditions that may impair their driving. This ensures that individuals are safe on the road while managing their health with medicinal cannabis.

Accessing Medicinal Cannabis Resources

All resources related to medicinal cannabis and driving are accessible via the Transport Victoria website. These resources provide essential information for both healthcare professionals and patients, ensuring that safety and legal compliance remain a priority.

Conclusion

The integration of medicinal cannabis into treatment plans is becoming increasingly common, and it is crucial for healthcare providers to equip patients with knowledge about driving risks. By fostering open conversations and utilizing the available resources, GPs can help ensure safer road practices for patients using medicinal cannabis.